Candidates develop in the laboratory to improve glioblastoma treatment (IMAGE)

Indian Institute of Technology Gandhinagar

Candidates develop in the laboratory to improve glioblastoma treatment

Caption

This illustration shows how SPK17 and SPK17b may work alongside temozolomide (TMZ), a chemotherapy drug, against glioblastoma, an aggressive brain cancer. The compounds are shown to promote DNA damage, reduce TTK protein activity, and disrupt tumour cell division, ultimately leading to programmed cell death. 

Credit

Please credit the Indian Institute of Technology Gandhinagar (IITGN).

Usage Restrictions

Please republish the images only with proper reference to the research paper.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.